Sangamo Therapeutics Inc (LTS:0R1D)
$ 2.18 -0.06 (-2.68%) Market Cap: 492.41 Mil Enterprise Value: 480.93 Mil PE Ratio: 0 PB Ratio: 12.55 GF Score: 41/100

Sangamo Therapeutics Inc Annual Shareholders Meeting Transcript

May 18, 2020 / 04:00PM GMT
Release Date Price: $7.27
Operator

Hello, and welcome to the 2020 Annual Stockholder Meeting of Sangamo Therapeutics. Please note that today's meeting is being recorded. (Operator Instructions) It is now my pleasure to turn today's meeting over to Sandy Macrae, President and Chief Executive Officer of Sangamo Therapeutics, who is serving as Chair of today's meeting. Dr. Macrae, the floor is yours.

Alexander D. Macrae
Sangamo Therapeutics, Inc. - CEO, President & Director

Good morning, everyone, and welcome to the 2020 Annual Stockholder Meeting of Sangamo Therapeutics. I am Sandy Macrae, and I'm the President and CEO of Sangamo Therapeutics, and I'm the chair of today's meeting. Also present virtually is Gary Loeb, Sangamo's General Counsel, who is serving as the secretary of this meeting.

It is my pleasure on behalf of Sangamo Therapeutics, its Board of Directors and its officers to extend to you a warm welcome and to express our appreciation for you attending this annual meeting. We especially appreciate your attendance during these unusual and challenging times, and we hope that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot